The company has substantially boosted the progress of a novel treatment for amyloid heart disease, employing the investigational drug. Initial clinical results reveals significant benefits for those affected from the https://biotech972792.suomiblog.com/firm-advances-amyloidosis-therapy-using-attruby-57996023